Kevin Raymond Merrill Smith Inogen Inc (INGN) insider trading activity

Kevin Raymond Merrill Smith is CEO and President of Inogen Inc. Currently has a direct ownership of 14,554 shares of INGN, which is worth approximately $124,873. The most recent transaction as insider was on Dec 01, 2024, when has been sold 13,779 shares (Common Stock) at a price of $9.71 per share, resulting in proceeds of $133,794. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.6K

n/a 3M change

n/a 12M change

Total Value Held $124,873

Kevin Raymond Merrill Smith Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Dec 01 2024	SELL Payment of exercise price or tax liability	$133,794 $9.71 p/Share	13,779 Reduced 48.63%	14,554 Common Stock
Dec 01 2024	BUY Exercise of conversion of derivative security	-	28,333 Added 50.0%	28,333 Common Stock

Also insider at

ONCS

ONCOSEC MEDICAL Inc Healthcare

Director

KRM